Glenmark Pharmaceuticals Limited

GLENMARK.NS·NSE
Compare
2,230.20+3.50 (+0.16%)today
As of Oct 19, 1:19 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,226.70
Open2,230.10
Day range2,213.002,269.90
52-week range1,792.602,537.60
Off day high−1.75%
Off 52-week high−12.11%
Volume166.16K
Avg. volume (3M)554.74K
Market cap629.42B
EPS (TTM)63.69
Forward P/E22.99
P/E ratio (TTM)35.02
Dividend yield0.11% (2.50)
Beta (5Y)—
Shares outstanding282.22M
Short interest—
Earnings dateJul 31, 2026 (est.)
Analyst target—
Profit margin—

Related companies

No related companies yet: the instruments index has no profile for GLENMARK PHARMACEUTICALS.

Latest news

All GLENMARK.NS news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.